Status:
COMPLETED
Perceptions and Representations of Vaccination Against COVID-19
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Collaborating Sponsors:
Centre Hospitalier Intercommunal Villeneuve Saint Georges
Conditions:
COVID-19 Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
SARS COV2, the virus that causes COVID-19, was first described in Wuhan, China. For this pathology, which causes severe respiratory infections, preventing the transmission of the virus has become fund...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Patient with a scheduled appointment in consultation or at the vaccination centre
- Not opposed to participation in the protocol
Exclusion
- Patient under guardianship or curatorship
- Patient unable to give free and informed consent
- Patient under court protection
- Patient without the cognitive capacity to ensure an interview
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04896957
Start Date
September 1 2021
End Date
September 1 2022
Last Update
December 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Villeneuve-Saint-Georges
Villeneuve-Saint-Georges, France